Recombinant multi-species DIPK2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DIPK2B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: DIPK2B,Divergent protein kinase domain 2B,Deleted in autism-related protein 1,DIA1R,CXorf36,PRO3743,EPQL1862,bA435K1.1,4930578C19Rik

Target products collectionGo to DIPK2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0887-Ab-1/ GM-Tg-hg-SE0887-Ab-2 Human DIPK2B protein Human
GM-Tg-rg-SE0887-Ab-1/ GM-Tg-rg-SE0887-Ab-2 Rat DIPK2B protein Rat
GM-Tg-mg-SE0887-Ab-1/ GM-Tg-mg-SE0887-Ab-2 Mouse DIPK2B protein Mouse
GM-Tg-cynog-SE0887-Ab-1/ GM-Tg-cynog-SE0887-Ab-2 Cynomolgus/Rhesus macaque DIPK2B monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0887-Ab-1/ GM-Tg-felg-SE0887-Ab-2 Feline DIPK2B protein Feline
GM-Tg-cang-SE0887-Ab-1/ GM-Tg-cang-SE0887-Ab-2 Canine DIPK2B protein Canine
GM-Tg-bovg-SE0887-Ab-1/ GM-Tg-bovg-SE0887-Ab-2 Bovine DIPK2B protein Bovine
GM-Tg-equg-SE0887-Ab-1/ GM-Tg-equg-SE0887-Ab-2 Equine DIPK2B protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0887-Ab-1/ GM-Tg-hg-SE0887-Ab-2; GM-Tg-rg-SE0887-Ab-1/ GM-Tg-rg-SE0887-Ab-2;
GM-Tg-mg-SE0887-Ab-1/ GM-Tg-mg-SE0887-Ab-2; GM-Tg-cynog-SE0887-Ab-1/ GM-Tg-cynog-SE0887-Ab-2;
GM-Tg-felg-SE0887-Ab-1/ GM-Tg-felg-SE0887-Ab-2; GM-Tg-cang-SE0887-Ab-1/ GM-Tg-cang-SE0887-Ab-2;
GM-Tg-bovg-SE0887-Ab-1/ GM-Tg-bovg-SE0887-Ab-2; GM-Tg-equg-SE0887-Ab-1/ GM-Tg-equg-SE0887-Ab-2
Products Name DIPK2B protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DIPK2B
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DIPK2B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.